Frequency distribution of genes encoding aminoglycoside modifying enzymes in uropathogenic E. coli isolated from Iranian hospital
© Soleimani et al.; licensee BioMed Central Ltd. 2014
Received: 16 February 2014
Accepted: 18 November 2014
Published: 25 November 2014
Escherichia coli is considered as the most common cause of urinary tract infection (UTI) and acquired multiple resistances to a wide range of antibiotics such as aminoglycosides. Enzymatic alteration of aminoglycosides (AMEs) by aminoglycoside- modifying enzymes is the main mechanism of resistance to these antibiotics in E. coli. The aim of this study was detection and investigation of frequency of genes encoding aminoglycoside modifying enzymes (aac(3)-IIa and ant(2′′)-Ia) in UPEC isolated from hospitalized patients in teaching hospital of Tehran, Iran.
A total of 276 UPEC were obtained from Urine samples in a hospital from Tehran. Antibiotic susceptibility to aminoglycosides was determined by disk diffusion method according CLSI guidelines in UPEC isolates. MICs of target antibiotics were determined by agar dilution method. All isolates were screened for the presence of the AMEs genes using the PCR. The results of disk diffusion showed 21%, 24.6%, 23.18%, 3.62% and 6.15% of isolates were resistant to Gentamicin, Tobramycin, Kanamicin, Amikacin and Netilmicin respectively. The agar dilution’s results (MICs) were high, 66.19% for Gentamicin. The aac (3)-IIa and ant(2″)-Ia genes were detected in (78.87%) and 47.88% of isolates respectively.
This study shows the high frequency of genes encoding (AMEs) aac(3)-IIa and ant(2”)-Ia genes and their relationship between different aminoglycoside resistance phenotypes.
KeywordsUPEC Aminoglycoside modifying enzymes and UTI
The aminoglycosides are potent bactericidal agents that inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit. They are often used in combination with either a b-lactam or a glycopeptide, especially in the treatment of Escherichia coli UTI, as these drugs act synergically [1, 2]. The application may be limited by the appearance of resistant strains in treatment. Various mechanisms are playing a role in the development of aminoglycoside resistance but the presence of aminoglycoside modifying enzymes is the most clinical and epidemiological importance [3, 4]. These enzymes are divided into three classes: aminoglycoside acetyltrans- ferases (AACs), aminoglycoside phosphotransferases (APHs) and aminoglycoside nucleotidyltransferases (ANTs) .
Urinary tract infection is one of the most common human infections, especially in young women and frequently influenced by sex and age and 20-30% of young women experienced this infection [6, 7]. Due to the importance of the resistance to aminoglycosides and the role of ant(2)-Ia, aac(3)II-a genes in mechanism, the main purpose of this study is the detection of resistance genes ant(2”)-Ia, aac(3)II-a in clinical isolates of aminoglycoside resistant E. coli isolated from urine of hospitalized patients in teaching hospital of Tehran, Iran, to know the prevalence and frequency of distribution of genes encoding aminoglycoside in Iranian population.
Materials and methods
A total of 276 clinical isolates of E. coli from urine specimens were randomly collected from Tehran Heart center. All isolates were then identified as E.coli using conventional microbiological tests. Informed written consent was obtained from the patients and the study was approved by the institutional ethics committee of Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran. Pure stock cultures of all isolates were stored frozen at −80°C in tryptic soy broth, containing 15% glycerol.
Antibiotic susceptibility testing
Antimicrobial susceptibility test for different E.coli isolates was performed against Gentamicin (10 μg), Tobramycin (10 μg), Kanamycin (30 μg), Amikacin (30 μg) and Nethelmicin 30 μg, (Mast, UK) by disc diffusion method. Sizes were interpreted using standard recommendations of CLSI . As the Gentamicin is the most applicable antibiotics to treat the infections due to gram positive and gram negative bacteria in Iranian patients, thus, Gentamicin MIC values were detected and the results were interpreted according to the CLSI guidelines.
DNA extraction and Polymerase Chain Reaction
Primer sequences for aminoglycoside resistance genes detection
Fragment (700 bp)
Fragment (740 bp)
Antibiotic resistance patterns (%) of E. coli isolates
Number of antibiotics resistant and showing pattern
Number of strains
GM,TN (n = 4) or GM,K (n = 13)
GM,N,TN,K (n = 13) or GM,AK,TN,K (n = 6)
Amplification and screening of genes encoding AME by PCR
Relationship between AME genes and different resistance Aminoglycosid patterns
Resistant phenotype *
GM, AK, N, TN, K
GM, AK, N, TN, K
GM, N, TN, K
GM, N, TN, K
GM, TN, K
Besides the side effects and increasing resistance, aminoglycosides play an important role in curing bacterial infections. Modification of aminoglycosides by aminoglycosides modifying enzymes is the common resistance mechanism against aminiglycosides in E.coli as these enzymes are not capable of binding to ribosomes of the cell [9, 10]. Resistance against Gentamicin, Kanamycin, Cizomycin and Tobramycin is mediated by ANT(2”)-Ia enzyme which is coded by ant(2”)-Ia gene in E.coli and also simultaneous resistance to Gentamycin and Tobramycin, mediated by AAC(3)-IIa enzyme which is coded by aac(3)-IIa gene .
In this study the prevalence of ant(2”)-Ia,aac(3)-IIa resistance genes in 71 aminoglycosides resistant E.coli isolates among 276 UTI isolates was determined by PCR. It is implied that 24.63% of isolates were resistant to tobramycin and the resistance rate against other 130 antibiotics were as following; Kanamycin 23.18%, Gentamicin 21.01%, Netilmicin 6.15% and Amikasin 3.62%. In 1999 Van hoof R and his colleagues reported that among 897 blood 132 isolates of Entrobacteriacea, 5.9% of isolates were resistance against Gentamycin, whereas 7.7% of isolates were resistant against Tobramycin,7.5% against netilmicin and 8.2% against Amikacin [11, 12]. In 2006 Kong and 2010 Lang Hoo and colleagues reported: 44 clinicalisolates of E.coli, the resistance rate against aminiglycosides were: Amikasin 18.18%, Gentamicin 56.82% and Tobramycin 63.36% and among 249 clinical isolates of E.coli 83.83% were resistant to Gentamicin respectively [13, 14].
The respective studies suggested an increasing resistance against aminoglycosides but the contradiction in results is due to different geographical areas and various numbers of different isolates. PCR results showed that 78.87% of isolates contained aac(3)-IIa resistance gene. In 2004, Minard showed that 17% of animal and 33% of human isolates contained the aac(3)-IIa resistance gene, aph(3)-Ia was detected in 6.97% and 4% of human isolates of Kanamycin resistant. Also, E.coli in 8% of animal isolates and 7.04% of human isolates of neomycin resistant while ant(2”)-Ia gene was not detected in this study . Jaconson et al.  studied 120 isolates of E. coli for occurrence of amino glycoside modifying enzymes namely ant(2”)-Ia, aac(3)-IIa and aac(3)-IV and also subjected the isolates to MIC for Gentamicin by dilution method. The E.coli isolates having aac(3)-IIa gene had high MIC’s, 32–512 mgs/ltr suggesting that, there is a correlation between MIC and specific ame production, but still not cleared . Jacobson et al. also studied 76 isolates of Gentamicin resistant E. coli which are 63.15% and contained aac(3)-IIa gene, although, ant(2”)-Ia gene was not screened in this study . In an epidemiological study in 2010 it was concluded that aac(3)-IIa (aaC2) gene was present in 84.1% of human isolates and 75.5% of animal isolates,while it was the common gene among the studied isolates .
Therefore, our results shows high frequency prevalence of aac(3)-IIa and ant(2”)-Ia genes, which were 47.88% and 78.87% respectively and also, demonstrated the relationship between AME genes and different aminoglycoside resistance phenotypes. According to the reviewed studies the prevalence of the respective genes has been increasing over time in various geographical patterns, which needs regular attention and determination.
In conclusion, our data show high frequency distribution of aac(3)-IIa and ant(2”)-Ia genes and their relationship between AME genes and different aminoglycoside resistance phenotypes. Further experiments will be needed to clarify the exact mechanisms and functions of these genes to controlled high prevalence of urinary tract infections caused by EPEC strains, increasing resistance against antibiotics in order to select the best medicine to avoid this confrontation.
This study was generously funded by tarbiat Modares University. The author LA sincerely thanks to DAAD for awarding a PhD Fellowship.
- Dornbusch K, Miller GH, Hare RS, Shaw KJ: Resistance to aminoglycoside antibiotics in gram- negative bacilli and Staphylococci isolated from blood. The ESGAR Study Group (European Study Group on Antibiotic Resistance). J Antimicrob Chemother. 1990, 26: 131-144.PubMedView ArticleGoogle Scholar
- Schmitz FJ, Jones ME: Antibiotics for treat- ment of infections caused by MRSA and elimination of MRSA carriage. What are the choices?. Int J Antimicrob Agents. 1997, 9: 1-19. 10.1016/S0924-8579(97)00027-7.PubMedView ArticleGoogle Scholar
- Udo EE, Dashti AA: Detection of genes en- coding aminoglycoside-modifying enzymes in Staphylococci by polymerase chain reaction and dot blot hybridization. Int J Antimicrob Agents. 2000, 13: 273-279. 10.1016/S0924-8579(99)00124-7.PubMedView ArticleGoogle Scholar
- Shaw KJ, Hare RS, Sabatelli FJ, Rizzo M, Cramer CA, Miller GH, Verbist L, Van Landuyt H, Glupczynski Y, Catalano M, Woloj M: Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrob Agents Chemother. 1991, 35: 2253-61. 10.1128/AAC.35.11.2253.PubMedPubMed CentralView ArticleGoogle Scholar
- Yadegar A, Sattari M, Nour Amir M, Gholam Reza G: Prevalence of the Genes Encoding Aminoglycoside-Modifying Enzymes and Methicillin Resistance Among Clinical Isolates of Staphylococcus aureus in Tehran, Iran. Microb Drug Resist. 2009, 15: 109-113. 10.1089/mdr.2009.0897.PubMedView ArticleGoogle Scholar
- Von Baum H, Marre R: Antimicrobial resistance of Escherichia coli and therapeutic implications. Intern J Med Microbiol. 2005, 295: 503-511. 10.1016/j.ijmm.2005.07.002.View ArticleGoogle Scholar
- Santo E, Mendonca Salvador M, Moacir MJ: Multidrug-Resistant Urinary Tract Isolates of Escherichia coli from Ribeirão Preto, São Paulo, Brazil. Brazilian J Infect Dis. 2007, 11: 575-578.Google Scholar
- Clinical and Laboratory Standards Institute/NCCLS: Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. 2007, Wayne, PA: CLSI/NCCLS document M100-S17. CLSIGoogle Scholar
- Bellaaj A, Bollet C, Ben-Mahrez K: Characterization of the 3-N-aminoglycoside acetyltransferase gene aac(3)-IIa of a clinical isolate of Escherichia coli. Annal Microbiol. 2003, 53: 211-217.Google Scholar
- Choi SM, Kim SH, Kim HJ, Lee DG, Choi JH, Yoo JH, Kang JH, Shin WS, Kang MW: Multiplex PCR for the detection of genes encoding aminoglycoside modifying enzymes and methicillin resistance among Staphylococcus species. J Korean Med Sci. 2003, 8: 631-636.View ArticleGoogle Scholar
- Chandrakanth RK, Raju S, Patil SA: Aminoglycoside-resistance mechanisms in multidrug-resistant Staphylococcus aureus clinical isolates. Curr Microbiol. 2008, 56: 558-562. 10.1007/s00284-008-9123-y.PubMedView ArticleGoogle Scholar
- Vanhoof RJ, Nyssen H, Van Bossuyt E, Hannecart-Pokorni E, and the Aminoglycoside Resistance Study Group: Aminoglycoside resistance in Gram-negative blood isolates from various hospitals in Belgium and the Grand Duchy of Luxembourg. J Antimicrob Chemother. 1999, 44: 483-488. 10.1093/jac/44.4.483.PubMedView ArticleGoogle Scholar
- Kong HS, Li XF, Wang JF, Wu MJ, Chen X, Yang Q: Evaluation of aminoglycoside resistance phenotypes and genotyping of acetyltransferase in Escherichia coli. Zheijang J. 2006, 35: 83-6.Google Scholar
- Leung Ho PC, Wong RW, Lo S, Chow KS, Wong S, Lun Que T: Genetic identity of aminoglycoside resistance genes in Escherichia coli isolates from human and animal sources. J Med Microbiol. 2010, 34: 145-155.Google Scholar
- Jakobsen L, Sandvang DF, Jensen VM, Seyfarth A, Frimodt-Moller NM, Hammerum A: Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints. Clin Microbiol Infect. 2007, 13: 816-842. 10.1111/j.1469-0691.2007.01761.x.View ArticleGoogle Scholar
- Jakobsen L, Dorthe S, Lars HH, Line B, Henrik W, Claus J, Dennis SH, Bodil MP, Dominique LM, Niels F, Søren JS, Anette MH: Characterization, dissemination and persistence of gentamicin resistant Escherichia coli from a Danish university hospital to the waste water environment. Environ Intern Microbiol. 2008, 34: 108-115.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.